MicroRNA-5195-3p enhances the chemosensitivity of triple-negative breast cancer to paclitaxel by downregulating EIF4A2.

Conclusion: These data demonstrate that miR-5195-3p might be a potential therapeutic target to reverse chemoresistance in TNBC through its targeting of EIF4A2. PMID: 31308851 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31308851?dopt=Abstract

Source: Mol Biol Cell - July 17, 2019 Category: Molecular Biology Authors: Liu M, Gong C, Xu R, Chen Y, Wang X Tags: Cell Mol Biol Lett Source Type: research